The iliac fossa is the standard site for a kidney allograft. In rare cases, the iliac veins or the inferior vena cava may be occluded or congenitally absent-thus, an alternative site and type of venous drainage are required. We report herein a case of intraabdominal kidney transplantation in a young patient whose infrarenal vena cava was absent. We also review the pertinent literature on this subject.
The recipient was an 18-year-old man with end-stage renal failure due to congenital bilateral kidney hypoplasia. He began hemodialysis at age 7. At age 9, he received a cadaver kidney graft that was placed in the right iliac fossa. The iliac vein and inferior vena cava were noted to be absent; they had been replaced by a conglomerate of tortuous vessels, to which the transplant renal vein was attached. Although immediate graft function was satisfactory, it was gradually lost due to repeated rejection episodes. At age 12, he received a second kidney graft (donated by his father) that was placed in the left iliac fossa. Again, a venous conglomerate was found but no iliac vein. One of these vessels was used as the recipient site for venous connection. Graft thrombosis occurred and the graft was removed on postoperative day 1. The patient re turned to peritoneal dialysis and later to hemodialysis. He also suffered from repeated episodes of deep venous throm bosis of the lower extremities, Coagulation study results, including levels of protein C, protein S, and antithrombin III, were normal.
At age 19, he was referred to the University of Minnesota for evaluation for a third kidney transplant. A venogram showed absence of the inferior vena cava below the level of the right gonadal vein; a large lumbar vein was present on the left side. This vein presumably was responsible for ve nous drainage of the lower abdomen and lower extremities through a collateral paravertebral venous network. In both iliac fossae, a network of tortuous vessels was present, but no iliac vein (Fig. 1) . The patient's brother, a 23-year-old HLAidentical match, was medically eligible for living-related do nation. An angiogram showed that his right kidney was supplied by three arteries; his left kidney, supplied by two arteries, was selected for procurement.
On June 23, 1994, an intraabdom inal kidney transplant was done through a midline incision (Fig. 2) . The recipient's right kidney was absent and his left kidney was atrophic. The inferior vena cava was atretic below the level of the right gonadal vein. Both the right and the left renal veins were of small caliber. A large lum bar vein was present on the left side. During dissection, patency of these collateral veins was preserved, to conserve blood flow and minimize the risk of postoperative thrombosis. The donor operation was routine, except that the entire length of ureter was mobilized. After recipient dissection, vascular clamps were placed on the infrahepatic vena cava and on the aorta. A venotomy was done on the infrahepatic vena cava, and an excellent backflow was noted. This venotomy served as the recipient site for the end-to-side venous anastomosis. The two renal arteries were separately anastomosed end-to-side to the recipient aorta. The ureter was drawn through a retroperitoneal tunnel mim icking the normal anatomy, and an intravesical ureteroneocystostomy was done using the Leadbetter-Politano tech nique. Immunosuppression consisted of cyclopsorine, prednisone, azathioprine, and an induction course of anti lymphocyte therapy (ATGAM, Upjohn). G raft function was excellent immediately. Low-do se heparin (200 units/h) was administered, then low-dose coumadin (3 mg/day). Now, at 2 months posttransplant, the serum creatinine level is 1 mg/dl.
Hetero topic placement of kidney allografts in the iliac fossa is the norm. In some circumstances, however, abnormalities of the venous system may preclude use of this site. Such abnormalities include absence of suitable iliac veins or of the intraabdominal vena cava. They can be congenital, or secondary to thrombosis related to hypercoagulability, previous placement of a vena cava filter, traum a, or perinatal catheterization of the umbilical vein (1) (2) (3) (4) (5) . Total absence of the vena cava is a rare congenital anomaly, often associated with cardiac or other vis ceral malformations (e.g., malrotation, dextrocardia, malforma tion of the spleen) (5). The precise cause of the absent iliac vein and infrarenal vena cava in our patient remains unclear.
Whatever the cause of the venous anomaly, a uniform consequence is inappropriate venous drainage from the lower extremities. This was reflected in our patient by repeated episodes of deep venous thrombosis, and even more dramat ically by the rapid graft thrombosis after his second trans plant. An important lesson from this case is to use caution when placing a kidney graft in the iliac fossa in the absence of normal venous anatomy. Venous congestion and graft thrombosis may occur. In an experimental study, all minipigs who underwent a kidney autotransplant after resection of the vena cava developed graft thrombosis, despite develop ment of a collateral circulation before cavai resection (4) . Therefore, patients with end-stage renal disease who have no suitable iliac vein or vena cava require an alternative graft site (intraabdominal or native lumbar fossa) and type of venous drainage (cavai or portal).
If only the infrarenal vena cava is absent, the vena cava immediately below the liver can be used for graft venous implantation, as in this case. Patency of the infrahepatic vena cava can be assessed preoperatively by venogram and confirmed intraoperatively by an adequate backflow after venotomy. All venous tributaries from this segment of upper vena cava (remnant renal veins, gonadal veins, lumbar veins) must be left intact, both to maximize the blood flow in this residual portion of the vena cava and to preserve collateral circulation and venous drainage from the lower abdomen and lower extremities. Finally, the venotomy should be made as large as possible to ensure a widely patent anastomosis and adequate venous emptying from the allograft. Alternatively, one of the native renal veins may serve as the recipient site for an end-to-side anastomosis w ith the transplant renal vein. We employed this technique in another kidney recipient F igure 2, Illustration of the intraabdominal transplant in the ab sence of the infrarenal vena cava. Renal vein was attached end-toside to the infrahepatic vena cava. Renal arteries were attached end-to-side to the aorta. An intravesical ureteroneocystostomy was performed.
with thrombosis of the infrarenal vena cava secondary to the use of a vena cava filter (I). At our institution, we have used an enlarged patent ovarian vein for venous implantation of a pancreas allograft in a patient with no suitable vena cava (Sutherland DER, unpublished observations).
If the vena cava is totally absent due to extensive throm bosis or agenesis, the only option is to use the portal system for graft implantation. The feasibility of draining various organ allografts (kidneys, heart, pancreas, small bowel) into the portal system has been demonstrated experimentally (5) (6) (7) (8) , Clinically, the splenic vein has been successfully used to drain pancreas allografts (9) (10) (11) , We have used recipient inferior mesenteric vessels to revascularize segmental pan creas allografts; the graft splenic artery and vein were anas tomosed end-to-end to the inferior mesenteric vessels, and no thrombosis occurred (12) .
We know of only two reports of intraabdominal kidney transplants using the portal system for venous revascular ization. One recipient was a child who had previously under gone nephrectomy and vena cava resection for Wilms* tumor; the renal artery was anastomosed end-to-side to the recipient aorta and the renal vein end-to-side to the splenic vein. Urinary continuity was restored by ureteroureterostomy, Ra dioisotopic scan 1 year posttransplant showed good perfusion and no signs of urinary stasis (IS). In another recipient, the inferior mesenteric vein was used for revascularization; similar to our case, the ureter was reimplanted into the bladder using the standard nonrefluxing Leadbetter-Politano technique (14) ,
There is a theoretical immunologic advantage in using the portal system for venous connection. Several reports indicate th a t rejection can be ameliorated by portal drainage, an effect possibly due to inactivation by the liver of circulating transplant antigens (8) . Experimentally, in certain strain of ra ts, port ally drained kidney, heart, and small bowel al lografts survive longer (5) (6) (7) (8) . The clinical reality of this effect rem ains controversial since it has not been repeatedly ob served in larger animals (15) . Based on the few human cases o f por tally drained kidney and pancreas allografts, there is no evidence that portal implantation dramatically amelio ra te s rejection, Using the portal system for graft vascular connection may even convey a physiologic disadvantage: por ta l pressure is higher than cavai pressure, a hemodynamic difference that could impair the venous drainage of port ally versus systemically drained allografts.
One alternative to intra ab dominai placement is the orthotopic position. Gil-Vernet described a graft placement in the native kidney fossa through an extraperitoneal lumbar ap proach, similar to that used for nephrectomy from a living donor. The transplant renal artery was attached end-to-end to the splenic artery or end-to-side to the aorta, and the transplant renal vein was attached end-to-end to the native ren al vein. Pyelopyelostomy was used for urinary reconstruc tion (10, 11) . Similarly, Talbot-Wright described a splenore n a l anastomosis in two patients with total agenesis of the inferior vena cava. The kidney was placed orthotopically, w ith end-to-end anastomosis of the transplant renal vein to th e native splenic vein and of the transplant renal artery to th e native splenic artery. In unexperienced hands, the ortho topic method conveys a significant risk of pancreatic injury (16) , We believe this delicate technique should be used only in patients with abnormal venous anatomy in whom intra abdominal placement is not feasible.
When the vascular anastomoses are in the upper abdomen, reconstructing the urinary tract is more difficult. Of concern is the excessive distance between the graft and the bladder and the resulting risk of ischemia and stenosis of the distal ureter. However, an auto transplanted ureter, by definition completely deprived of its original blood supply, does survive with normal peristalsis and appearance and with preserved histology. Neovascularization can develop due to either repermeabilization of original vessels or to formation of new ones (17) . Neovascularization of recipient origin can be im proved by keeping periureteral tissues intact during procure ment and by drawing the ureter through a retroperitoneal tunnel, as in our case. Development of new vessels can also be improved by wrapping the ureter with a pedicle of great omentum (18) . Finally, a factor limiting the feasibility of a direct uretereroneocystostomy may be an insufficient length of available donor ureter. In such a case, a pyelopyelostomy or ureteroureterostomy can be done if the recipient urinary tract is anatomically intact and the vesicoureteral reflux is absent.
In summary, our technique allowed us to safely do a livingrelated kidney transplant after a standard heterotopic tra n s plant had failed due to the absence of the infrarenal vena cava. The recipient would otherwise have been condemned to lifetime dialysis. multiple small discrete parenchymal calcifications compati ble with medullary nephrocalcinosis.
The mild renal tubular acidosis secondary to acetazol amide therapy was considered to be responsible for the pa tient's medullary nephrocalcinosis and deterioration in renal function. The acetazolamide was discontinued and the pa tient's creatinine fell to 136 p m o V L in one year and later to 95-105 jumol/L. Serum bicarbonate rose to 27 and chloride fell to 107 mmol/L. Urine pH fell to the 5-6 range, and red blood cells and white blood cells to 2-4 per high power field on urinalysis. At age 44, the patient has done well without passing any calculi or having any episodes of renal colic. The creatinine has remained stable, and follow-up radiographs and sonograms have demonstrated no change from the pa tient's initial nephrocalcinosis at age 31. He has not been treated for transplant rejection since age 22. The glaucoma became stable on 10 mg daily oral prednisone and timolol 0,5% and isoptocarpine 2% eye drops.
Nephrocalcinosis, calcifications located within the renal parenchyma, is classified as cortical or medullary. Cortical
